Bronchoscopic valves for prolonged air leak: current status and technique

Area of Science:

• Pulmonary Medicine
• Interventional Pulmonology
• Medical Devices

Background:

• Unidirectional airway valves were initially explored for non-surgical lung volume reduction in COPD patients.
• Despite initial trials for LVRS not achieving FDA approval, a Humanitarian Device Exemption was granted for Spiration intrabronchial valves (IBVs) for persistent air leaks (PALs).
• IBVs are increasingly used for PALs due to their efficacy in reducing air leak duration and associated hospital complications.

Purpose of the Study:

• To review the current literature and clinical utility of unidirectional airway valves for managing persistent air leaks.
• To highlight the effectiveness of IBVs in treating alveolar-pleural fistulas (APF) and bronchopleural fistulas (BPFs).

Main Methods:

• Literature review focusing on case reports and series evaluating unidirectional airway valves for PALs.
• Analysis of existing data on the use of Spiration IBVs for bronchoscopic treatment of air leaks.

Main Results:

• Unidirectional airway valves, particularly Spiration IBVs, demonstrate effectiveness in treating PALs.
• Utilization of these valves leads to shorter hospitalizations and reduced risk of hospital-associated complications.
• The current evidence base is largely derived from case reports and series.

Conclusions:

• Unidirectional airway valves are a valuable tool for managing persistent air leaks, offering a less invasive treatment option.
• Further multicenter, randomized trials are necessary to refine patient selection criteria and confirm long-term effectiveness.
• The existing literature, though limited, supports the growing clinical application of these devices.